(Q39481822)

12 September 2017

title

Cationic liposomal co-delivery of small interfering RNA and a MEK inhibitor for enhanced anticancer efficacy (English)

1 reference

12 September 2017

8

Yu-Kyoung Oh

1 reference

12 September 2017

3

Gayong Shim

1 reference

12 September 2017

6

Han-Gon Choi

1 reference

12 September 2017

Seung Hee Kang

1

1 reference

12 September 2017

Hee-Jeong Cho

2

1 reference

12 September 2017

Sangbin Lee

4

1 reference

12 September 2017

Su-Hyeon Kim

5

1 reference

12 September 2017

Chan-Wha Kim

7

1 reference

12 September 2017

language of work or name

1 reference

31 August 2011

1 reference

12 September 2017

published in

Pharmaceutical Research

1 reference

12 September 2017

volume

28

1 reference

12 September 2017

issue

12

1 reference

12 September 2017

page(s)

3069-3078

1 reference

Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Proof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Clinical experience of MEK inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

The Bcl-2 apoptotic switch in cancer development and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

siRNA delivery systems for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Efficient siRNA delivery with non-viral polymeric vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Amine-modified poly(vinyl alcohol)s as non-viral vectors for siRNA delivery: effects of the degree of amine substitution on physicochemical properties and knockdown efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Anionic amino acid-derived cationic lipid for siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Polyethylenimine-mediated cellular uptake, nucleus trafficking and expression of cytokine plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Chitosan-based formulations for delivery of DNA and siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0569-4

Pharmacodynamic and toxicokinetic evaluation of the novel MEK inhibitor, PD0325901, in the rat following oral and intravenous administration

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21879387

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Degradation of cellular mRNA is a general early apoptosis-induced event.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21879387

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21879387

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11095-011-0569-4

1 reference

12 September 2017

1 reference